Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

B7 2C Occlusion Balloon

K-Number: K171492 · 2017-11-20

Decision Date2017-11-20
Product CodeEOQ
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

B7 2C Occlusion Balloon is a medical device manufactured by Spiration, Inc.. It received FDA 510(k) clearance on 2017-11-20 under approval number K171492. The device is classified under product code EOQ. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the B7 2C Occlusion Balloon?

B7 2C Occlusion Balloon is a medical device that received FDA 510(k) clearance on 2017-11-20. It is manufactured by Spiration, Inc.. The 510(k) number is K171492.

When was B7 2C Occlusion Balloon approved by the FDA?

B7 2C Occlusion Balloon received FDA 510(k) clearance on 2017-11-20, under approval number K171492.

What company makes B7 2C Occlusion Balloon?

B7 2C Occlusion Balloon is manufactured by Spiration, Inc..

What is the FDA product code for B7 2C Occlusion Balloon?

The FDA product code for B7 2C Occlusion Balloon is EOQ.

Related Clinical Trials

Other Devices by Spiration, Inc.

Related Devices (Code: EOQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.